Mutares, Clears

Mutares Clears Regulatory Hurdle While Its Deal Machine Grinds On

Published on 08/31/2026 at 03:12 | Editorial boerse-global.de

Mutares shares trade 26% below peak despite record SABIC acquisition, EBITDA swing to €67M, and BaFin closure.

Mutares Stock Lags Despite Record SABIC Deal and EBITDA Turnaround
Mutares Clears Regulatory Hurdle While Its Deal Machine Grinds On Illustration mit AI erstellt übermittelt durch boerse-global.de

The German holding company's stock has spent much of 2026 drifting below its 200-day moving average, even as the underlying portfolio churns through acquisitions and divestitures at a pace that would test most rivals. Shares last changed hands at €25.95, roughly 26 percent off the January peak of €35.15, with a 14 percent decline since the start of the year. The 200-day average of €28.75 sits comfortably above the current price, a technical signal that the market has yet to fully embrace the turnaround story.

That gap between operational momentum and share-price performance has become the defining tension for Mutares investors. The first half of 2026 delivered group revenue of €3.4 billion, up 9 percent from €3.1 billion a year earlier. More strikingly, adjusted EBITDA swung from a negative €89 million to a positive €67 million — an improvement of more than €150 million year on year. Yet the holding company's net result, stripped of €10 million in capital market costs, came in at just €6 million, a far cry from the €70 million posted in the prior-year period.

Regulatory Closure and a Record-Breaking Acquisition

Part of the overhang has now been removed. BaFin, Germany's financial regulator, has concluded its review of the 2023 annual financial statements, flagging a missing note on the residual maturities of receivables from affiliated companies. Mutares had already supplied that information in its 2024 and 2025 filings, including a retroactive presentation as of the end of 2023. The matter was formal rather than operational, but its resolution removes a layer of regulatory uncertainty that had lingered over the stock.

The bigger story, however, remains the sheer scale of recent dealmaking. Just over a week ago, Mutares closed the acquisition of SABIC's Engineering Thermoplastics business — a $450 million enterprise-value transaction that stands as the largest in the company's history. The unit, operating under the name NexPoint Materials, generates around €2.0 billion in annual revenue with roughly 2,800 employees across eight sites.

That deal followed the completed purchase of Car Top Systems from Magna, a specialist in roof and kinematics solutions based in Bietigheim-Bissingen with approximately €75 million in revenue. The business now sits within the Automotive & Mobility segment alongside the HILO Group. Meanwhile, the planned acquisition of Stellantis' Free2move carsharing operation remains in regulatory review, with completion expected by the end of 2026.

Should investors sell immediately? Or is it worth buying Mutares?

Exits and Balance-Sheet Discipline

The acquisition spree has been matched by a steady stream of divestitures. Mutares recently sold Walor Precision Turning to Reed Capital and offloaded Finnish damage-repair specialist Redo Oy to the Invex Group — exits that underscore the group's core playbook of buying, restructuring, and selling at a profit.

The next disposal on the horizon is NEM, a portfolio company expected to fetch more than €100 million. That would provide fresh firepower for further deals, including a Czech chemical-sector acquisition slated to close in the third quarter of 2026.

Mid-August brought another piece of reassuring news: Mutares confirmed the restoration of full compliance with all bond covenants, a signal that its financing structure remains sound despite the aggressive expansion. That announcement, made alongside the half-year report, was aimed squarely at investors who had grown wary of the balance-sheet strain from months of relentless buying.

Pay Packet Draws Attention

Not all the news has been smooth. This week's compensation report revealed that CFO Mark Friedrich earned just under €2.3 million in annual pay, a figure that has drawn criticism from some observers given the regulatory scrutiny the company has faced. The debate over executive compensation runs parallel to broader questions about capital discipline — a topic that has clearly been front of mind for the company's bondholders and shareholders alike.

What's Next

Management has confirmed its full-year guidance: revenue between €7.9 billion and €9.1 billion, up from €6.5 billion last year, with holding-level net income projected at €165 million to €200 million. At the annual general meeting in early July, the board proposed a dividend of €2.00 per share, framed as a minimum payout.

The market's muted reaction — a 1.2 percent gain on Friday but a 3.7 percent decline over the past seven days — suggests investors are waiting for proof that the integration machine can convert acquisitions into sustained earnings. The next major checkpoint arrives on November 19, when Mutares hosts an investor day in London with a focus on its international expansion strategy, particularly in the United States. Whether the promised stronger second half materializes and the various integration projects run smoothly will likely determine whether the stock can finally close the gap to its moving average.

Ad

Mutares Stock: New Analysis - 31 August

Fresh Mutares information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Mutares analysis...

Disclaimer...

en | DE000A2NB650 | MUTARES | boerse | 70026419 |